35th week of 2018 patent applcation highlights part 9 |
Patent application number | Title | Published |
20180243309 | TOPICAL ANTIVIRAL COMPOSITIONS | 2018-08-30 |
20180243310 | Pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[4- -methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof | 2018-08-30 |
20180243311 | INHIBITORS OF BRUTON'S TYROSINE KINASE | 2018-08-30 |
20180243312 | TGF BETA RECEPTOR ANTAGONISTS | 2018-08-30 |
20180243313 | COMPOSITIONS COMPRISING PHOSPHOINOSITIDE 3-KINASE INHIBITORS AND A SECOND ANTIPROLIFERATIVE AGENT | 2018-08-30 |
20180243314 | NO-DONORS FOR THE TREATMENT OF CEREBROVASCULAR VASOSPASMS AFTER BRAIN HEMORRHAGE | 2018-08-30 |
20180243315 | INHIBITORS OF HUMAN EZH2, AND METHODS OF USE THEREOF | 2018-08-30 |
20180243316 | SALT FORM OF A HUMAN HISTONE METHYLTRANSFERASE EZH2 INHIBITOR | 2018-08-30 |
20180243317 | COMPOSITIONS COMPRISING A PI3K INHIBITOR AND AN HDAC INHIBITOR | 2018-08-30 |
20180243318 | PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF | 2018-08-30 |
20180243319 | MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS | 2018-08-30 |
20180243320 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | 2018-08-30 |
20180243321 | COMPOSITION AND MEDICAL DEVICE COMPRISING ACETYLSALICYLIC ACID FOR THE TREATMENT OF HUMAN PAPILLOMA VIRUS SKIN INFECTIONS | 2018-08-30 |
20180243322 | Neridronic Acid for Treating Complex Regional Pain Syndrome | 2018-08-30 |
20180243323 | PHOSPHOLIPID PREPARATIONS FOR THE IMPROVEMENT OF SLEEP | 2018-08-30 |
20180243324 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITORY ACTIVITY | 2018-08-30 |
20180243325 | METHOD FOR INHIBITING ABSORPTION OF AND/OR PROMOTING EXCRETION OF LIPIDS USING D-PSICOSE | 2018-08-30 |
20180243326 | INTRACELLULAR ATP ENHANCER | 2018-08-30 |
20180243327 | USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION DAMAGE | 2018-08-30 |
20180243328 | NOVEL 6-6 BICYCLIC AROMATIC RING SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS | 2018-08-30 |
20180243329 | STABILIZATION METHOD OF FUNCTIONAL NUCLEIC ACID | 2018-08-30 |
20180243330 | Method of Treating Severe Asthma | 2018-08-30 |
20180243331 | METHOD OF INHIBITING QUORUM SENSING IN PSEUDOMONAS AERUGINOSA | 2018-08-30 |
20180243332 | METHOD OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION | 2018-08-30 |
20180243333 | BICARBONATE AS A POTENTIATOR FOR ANTIMICROBIAL AGENTS | 2018-08-30 |
20180243334 | USE OF CHLORITE TO TREAT RED BLOOD CELL DISEASES AND INDICATIONS MEDIATED THEREBY | 2018-08-30 |
20180243335 | METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISORDERS | 2018-08-30 |
20180243336 | ANTIMICROBIAL AND ENZYME INHIBITORY ZINC OXIDE NANOPARTICLES | 2018-08-30 |
20180243337 | COMBINED ORGAN AND HEMATOPOIETIC CELLS FOR TRANSPLANTATION TOLERANCE OF GRAFTS | 2018-08-30 |
20180243338 | MEDICINE FOR TREATMENT AND/OR PREVENTION OF ISCHEMIC DISEASES, METHOD FOR IMPROVING ANGIOGENESIS-PROMOTING ACTIVITY OF CELLS, OR METHOD FOR PRODUCING MEDICINE | 2018-08-30 |
20180243339 | METHOD FOR TREATING MIGRAINE HEADACHES | 2018-08-30 |
20180243340 | COMBINATION THERAPY COMBINING CAR + T CELLS WITH APPROPRIATELY TIMED IMMUNODULATORY ANTIBODIES | 2018-08-30 |
20180243341 | Methods and Compositions for Cells Expressing a Chimeric Intracellular Signaling Molecule | 2018-08-30 |
20180243342 | METHODS FOR PRODUCING AND USING REJUVENATED RED BLOOD CELLS | 2018-08-30 |
20180243343 | METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PARKINSON'S DISEASE | 2018-08-30 |
20180243344 | OXYGENATED DEMINERALIZED BONE MATRIX FOR USE IN BONE GROWTH | 2018-08-30 |
20180243345 | METHOD FOR INCREASING MUSCLE GROWTH USING KRILL EXTRACT | 2018-08-30 |
20180243346 | Discovery of Root Cause of Autoimmune Disease; Rheumatoid Arthritis and Osteoarthritis | 2018-08-30 |
20180243347 | IMMUNOMODULATORY COMPOSITIONS AND METHODS OF USE THEREOF | 2018-08-30 |
20180243348 | HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS | 2018-08-30 |
20180243349 | MICROBIOTA RESTORATION THERAPY (MRT) COMPOSITIONS AND METHODS OF MANUFACTURE | 2018-08-30 |
20180243350 | THERAPEUTIC AND PROPHYLACTIC COMPOSITION PRODUCED BY MICROBIOTA | 2018-08-30 |
20180243351 | BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS | 2018-08-30 |
20180243352 | LACTIC ACID BACTERIA, NATURAL IMMUNOACTIVATOR AND INFECTION PREVENTATIVE/THERAPEUTIC DERIVED FROM SAID LACTIC ACID BACTERIA, AND FOOD/BEVERAGE | 2018-08-30 |
20180243353 | COMPOSITION AND METHOD FOR TREATMENT AND PROPHYLAXIS OF INTESTINAL INFECTION AND INFLAMMATION | 2018-08-30 |
20180243354 | PROCESS FOR THE MANUFACTURE OF PATHOGEN INHIBITING BACTERIA | 2018-08-30 |
20180243355 | ANTI-CANCER AGENT COMPRISING HVJ-E AND CXCL2 | 2018-08-30 |
20180243356 | INTEGRATIVE FUNGAL SOLUTIONS FOR PROTECTING BEES | 2018-08-30 |
20180243357 | COMBINED COMPOSITIONS FOR CONTROLLING BLOOD SUGAR LEVELS, HEPATOPROTECTION, AND FOR PREVENTION AND TREATMENT OF RELATED MEDICAL CONDITIONS | 2018-08-30 |
20180243358 | COMPOSITION CONTAINING ANGELICA EXTRACT FOR PROMOTING PROLIFERATION OF STEM CELLS DERIVED FROM BONE MARROW | 2018-08-30 |
20180243359 | SYNERGISTIC ANTIBACTERIAL EFFECTS OF MAGNOLIA BARK EXTRACT AND L-ARGININE, N-ALPHA-LAUROYL ETHYL ESTER ON PLAQUE BIOFILM | 2018-08-30 |
20180243360 | ANTI-FATIGUE COMPOSITION USED FOR INCREASING ENDURANCE PERFORMANCE, AND USE OF THE SAME | 2018-08-30 |
20180243361 | COMPOSITION COMPRISING NATURAL COMPLEX EXTRACT AS ACTIVE INGREDIENT | 2018-08-30 |
20180243362 | METHOD FOR PRODUCING DRY EXTRACTS | 2018-08-30 |
20180243363 | NEUROKININ 1 RECEPTOR AGONIST MEDIATED PROTECTION OF THE EYE | 2018-08-30 |
20180243364 | MODULATION OF TUMOR IMMUNITY BY PROTEIN-MEDIATED 02 DELIVERY | 2018-08-30 |
20180243365 | PEPTIDE INHIBITORS OF CLOSTRIDIUM DIFFICILE TCDB TOXIN | 2018-08-30 |
20180243366 | DRUG CONTAINING RECOMBINANT MISTLETOE LECTINS FOR TREATING MALIGNANT MELANOMA | 2018-08-30 |
20180243367 | Inhibitor of IGFBP3/TMEM219 Axis and Diabetes | 2018-08-30 |
20180243368 | MOLECULAR SIGNATURE OF CANCER | 2018-08-30 |
20180243369 | ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN RADIONUCLIDE THERAPY | 2018-08-30 |
20180243370 | METHODS AND COMPOSITIONS FOR TREATMENT OF GAUCHER DISEASE VIA MODULATION OF C5A RECEPTOR | 2018-08-30 |
20180243371 | MUSSEL ADHESIVE PROTEIN PRODUCT AND USE THEREOF FOR TREATING MUCOSAL INFLAMMATION | 2018-08-30 |
20180243372 | B7-H1 Fusion Polypeptides for Treating and Preventing Organ Failure | 2018-08-30 |
20180243373 | TOPICAL ERYTHROPOIETIN FORMULATIONS AND METHODS FOR IMPROVING WOUND HEALING WITH AND COSMETIC USE OF THE FORMULATIONS | 2018-08-30 |
20180243374 | COMPOSITION FOR DIAGNOSING, PREVENTING, OR TREATING VASCULAR SMOOTH MUSCLE CELL PROLIFERATIVE DISEASES USING FGF12 | 2018-08-30 |
20180243375 | Modified FGF-21 Polypeptides and Uses Thereof | 2018-08-30 |
20180243376 | METHODS AND NON-IMMUNOGENIC COMPOSITIONS FOR TREATING INFLAMMATORY DISORDERS | 2018-08-30 |
20180243377 | IFN-ALPHA/BETA-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION THROUGH A NOVEL LIGAND-RECEPTOR PAIR: IFN-LAMBDA LIGANDS ENGAGE A NOVEL RECEPTOR IFN-LAMBDA R1 (CRF2-12) AND IL-10R2 (CRF2-4) FOR SIGNALING AND INDUCTION OF BIOLOGICAL ACTIVITIES | 2018-08-30 |
20180243378 | TREATING CARDIOVASCULAR OR RENAL DISEASES | 2018-08-30 |
20180243379 | Treatment of Type 2 Diabetes Mellitus Patients | 2018-08-30 |
20180243380 | RAPID ACTION INSULIN FORMULATIONS AND PHARMACEUTICAL DELIVERY SYSTEMS | 2018-08-30 |
20180243381 | Formation of Bone | 2018-08-30 |
20180243382 | TARGETING MDA-5 ACTIVATION FOR CANCER IMMUNOTHERAPY | 2018-08-30 |
20180243383 | USE OF APC ANALOGUE FOR WOUND HEALING | 2018-08-30 |
20180243384 | METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES | 2018-08-30 |
20180243385 | METHODS FOR INDUCING SELECTIVE APOPTOSIS | 2018-08-30 |
20180243386 | IDENTIFICATION OF CD8+ T CELLS THAT ARE CD161HI AND/OR IL18R(ALPHA)HI AND HAVE RAPID DRUG EFFLUX CAPACITY | 2018-08-30 |
20180243387 | TECHNOLOGY FOR CONTROLLING IMMUNE CELLS | 2018-08-30 |
20180243388 | COMPOSITIONS AND METHODS FOR TREATING MELANOMA | 2018-08-30 |
20180243389 | FUSION PROTEINS COMPRISING MODIFIED ALPHA VIRUS SURFACE GLYCOPROTEINS AND TUMOR ASSOCIATED ANTIGEN AND METHODS THEREOF | 2018-08-30 |
20180243390 | INFLAMMASOME ACTIVATORS AND METHODS OF USE TO TREAT TUMORS | 2018-08-30 |
20180243391 | VACCINATIONS AGAINST LYME DISEASE | 2018-08-30 |
20180243392 | CS21 AND LNGA PROTEIN VACCINES | 2018-08-30 |
20180243393 | METHODS AND COMPOSITIONS FOR IMMUNE PROTECTION AGAINST EXTRA-INTESTINAL PATHOGENIC E. COLI | 2018-08-30 |
20180243394 | STAPHYLOCOCCAL COAGULASE ANTIGENS AND METHODS OF THEIR USE | 2018-08-30 |
20180243395 | INJECTABLE VACCINES AGAINST MULTIPLE MENINGOCOCCAL SEROGROUPS | 2018-08-30 |
20180243396 | COMPOSITIONS AND METHODS FOR DETECTING, TREATING, AND PROTECTING AGAINST FUSOBACTERIUM INFECTION | 2018-08-30 |
20180243397 | NOROVIRUS VACCINE | 2018-08-30 |
20180243398 | PRRSV minor protein-containing recombinant viral vectors and methods of making and use thereof | 2018-08-30 |
20180243399 | FCV RECOMBINANT VACCINES AND USES THEREOF | 2018-08-30 |
20180243400 | ANTIGENS AND VACCINES DIRECTED AGAINST HUMAN ENTEROVIRUSES | 2018-08-30 |
20180243401 | Live-Attenuated Vaccine Having Mutations in Viral Polymerase for the Treatment and Prevention of Canine Influenza Virus | 2018-08-30 |
20180243402 | BIRD FLU VACCINE COMBINATION COMPRISING VIRUS-LIKE PARTICLES AND NOVEL ADJUVANTS | 2018-08-30 |
20180243403 | INFLUENZA HEMAGGLUTININ PROTEINS AND METHODS OF USE THEREOF | 2018-08-30 |
20180243405 | INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS | 2018-08-30 |
20180243406 | INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS | 2018-08-30 |
20180243407 | METHODS AND COMPOSITIONS FOR ELICITING AN IMMUNE RESPONSE AGAINST HEPATITIS B VIRUS | 2018-08-30 |
20180243408 | TOLERANCE THERAPEUTIC FOR TREATING POLYPEPTIDE INDUCED ALLERGY | 2018-08-30 |
20180243409 | SYNTHETIC CONJUGATE OF CpG DNA AND T-HELP/CTL PEPTIDE | 2018-08-30 |